Related Experiment Video
Updated: Jul 13, 2025

A 3D Organotypic Melanoma Spheroid Skin Model
Published on: May 18, 2018
The Diagnosis and Management of Cutaneous Metastases from Melanoma
Cosimo Di Raimondo1, Flavia Lozzi1, Pier Paolo Di Domenico1
1Department of Dermatology, University of Roma Tor Vergata, 00133 Rome, Italy.
Abstract:
Melanoma is one of the deadliest skin tumors, accounting for almost 90% of skin cancer mortality. Although immune therapy and targeted therapy have dramatically changed the prognosis of metastatic melanoma, many patients experience disease progression despite the currently available new treatments. Skin metastases from melanoma represent a relatively common event as first sign of advanced disease or a sign of recurrence. Skin metastases are usually asymptomatic, although in advanced stages, they can present with ulceration, bleeding, and superinfection; furthermore, they can cause symptoms related to compression on nearby tissues. Treatments vary from simple surgery resections to topical or intralesional local injections, or a combination of these techniques with the most recent systemic immune or target therapies. New research and studies should focus on the pathogenesis and molecular mechanisms of the cutaneous metastases of melanoma in order to shed light on the mechanisms underlying the different behavior and prognoses of different patients.
Insights
Melanoma skin metastases are common in advanced disease. Further research into their pathogenesis is needed to improve patient outcomes despite current therapies.
Area of Science:
- Oncology
- Dermatology
- Cancer Research
Background:
- Melanoma is a deadly skin cancer, causing most skin cancer deaths.
- Advanced melanoma treatments like immunotherapy have improved prognoses, but disease progression remains a challenge for many patients.
- Cutaneous (skin) metastases are frequent in advanced melanoma, signaling recurrence or advanced disease.
Purpose of the Study:
- To review the clinical presentation and management of melanoma skin metastases.
- To highlight the need for further research into the molecular mechanisms of melanoma metastasis to the skin.
- To understand the varying behaviors and prognoses associated with cutaneous melanoma metastases.
Main Methods:
- This review synthesizes current knowledge on melanoma skin metastases.
- It discusses existing treatment modalities, including surgery, local therapies, and systemic treatments.
- It emphasizes the importance of ongoing research into the pathogenesis of these metastases.
Main Results:
- Melanoma skin metastases can be asymptomatic or cause local symptoms like ulceration or bleeding.
- They often indicate advanced disease or recurrence.
- Current treatments are diverse, ranging from local interventions to systemic therapies.
Conclusions:
- Despite advances in melanoma treatment, understanding cutaneous metastases is crucial.
- Further investigation into the pathogenesis and molecular mechanisms of skin metastases is essential.
- This research may elucidate factors influencing different patient prognoses and treatment responses.
Related Concept Videos
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Skin Diseases and Disorders
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Changes in Skin Color: Clinical Perspectives
Albinism
Albinism is a genetic disorder that affects (completely or partially) the coloring of skin, hair, and eyes. The defect is primarily...
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...

